Brought to you by 
Former MGI Pharma execs form Tesaro; invest in Series A
28 Mar 2012
Executive Summary
Tesaro Inc. (cancer therapeutics and supportive care) has secured $60mm in Series A funding, beginning with a $10mm investment by New Enterprise Associates (NEA) and members of the company's management team. A further $10mm is expected within a year, according to the Form D, with yet another $40mm pledged by NEA.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Former MGI Pharma execs form Tesaro; invest in Series A
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice